[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on biological product deviation reporting for licensed manufacturers of biologica...[ Price : $8.95]
An FDA panel votes to recommend a label revision for breast cancer drug tamoxifen to reflect clinical evidence showing that women ...[ Price : $8.95]
FDA clears a InfraReDx 510(k) application to market a near-infrared spectroscopic system for examining coronary arteries.[ Price : $8.95]
Novartis extends a Canadian warning on Gleevec and cardiac risk to U.S. labeling.[ Price : $8.95]
The monthly meeting of the FDA Alliance gets a vivid picture of FDA poverty and a downtrodden staff from former FDA counsels Stuar...[ Price : $8.95]
Consumers tell the Wall Street Journal Online/Harris Interactive Health-Care Poll they are likely to go to mega-stores to buy disc...[ Price : $8.95]
FDA and FTC launch an enforcement initiative to stop deceptive Internet sales of bogus diabetes products.[ Price : $8.95]
FDA approves expanding Remicades indication to include maintaining clinical remission and mucosal healing in patients with moderat...